Edith Mathiowitz

Perosphere Technologies, Inc. is a private medical technologies company that is focused on developing and commercializing the novel POC (point-of-care) coagulometer. The company is based in Danbury, CT. This diagnostic tool informs diagnosis, treatment, and prevention through precision data, made immediately accessible to all. The POC coagulometer is the only point-of-care diagnostic tool that effectively and swiftly tests clotting times across drug classes, including direct oral anticoagulants (DOACs). The fast diagnosis and related appropriate treatment decisions the POC coagulometer enables will help establish a new standard of care in hospital emergency departments for patients at risk for bleeding and has the potential to improve efficiency, provide significant cost savings, and better patient outcomes. The CEO of the company is Sasha H. Bakhru.

Perosphere Pharmaceuticals, Inc. engages in the development of rescue drugs. Its pipeline include Ciraparantag, Felbamate, and Glucagon. The company is headquartered in Danbury, CT.

Memory Pharmaceuticals Corp. develops pharmaceutical products for the treatment of debilitating central nervous system (CNS) disorders such as Alzheimer's disease and schizophrenia. The company was founded by Axel Unterbeck in 1998 and is headquartered in Montvale, NJ.

Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY.

BioMed Transition Partners provides biomedical management services. The private company is based in New York, NY. The company was founded by Robert J. Beckman.

Phage Pharmaceuticals, Inc. manufactures therapeutic protein which makes use of a proprietary production method that improves upon well-established approaches for the manufacture of proteins and results in the production of simple, properly folded therapeutic proteins at high yields. The company was founded in 1998 and is headquartered in San Diego, CA.

Lesanne Life Sciences LLC operates as a stroke diagnostics company. The firm develops diagnostics foe the stroke, traumatic brain injury and CNS ischemia from CABG surgery. The company was founded by Ann H. Cornell-Bell, Leslie A. Riblet, Robert J. Beckman, Allan R. Goldberg and Philip N. Susman in 2006 and is headquartered in Ivoryton, CT.

Thar Pharmaceuticals, Inc. operates as a specialty pharmaceutical company. The firm focuses on transforming intravenous drugs into oral drugs for existing and new indications. The company was founded by Mazen Hanna and Raymond K. Houck and is headquartered in Pittsburgh, PA.

Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ.

Cass Pharmaceuticals, Inc. develops pharmaceutical products for diabetes. The company is based in Franklin, TN. The CEO of the company is Stephen J. McCormack.

Landsdowne Labs LLC engages in the provision of healthcare services. Its products include ChildLok, a button battery technology designed to deactivate batteries following accidental ingestion. The company was founded by Robert Langer, Melissa Fensterstock, and Jeff Karp and is headquartered in Stamford, CT.